1126-62-1

Usage

Uses

Used in Pharmaceutical Industry:
(3,4-DIHYDROXYPHENYL)ACETONITRILE is used as a key intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
(3,4-DIHYDROXYPHENYL)ACETONITRILE is used as a building block in the production of agrochemicals, aiding in the development of effective and environmentally friendly pesticides and other agricultural chemicals.
Used in Organic Synthesis:
(3,4-DIHYDROXYPHENYL)ACETONITRILE is used as a precursor in the synthesis of amino acids and other organic compounds, facilitating the creation of a wide range of chemical products.
Used in Dye and Pigment Production:
(3,4-DIHYDROXYPHENYL)ACETONITRILE is used as a precursor in the production of dyes and pigments, enabling the creation of vibrant and stable colorants for various applications.
Used in Specialty Chemicals:
(3,4-DIHYDROXYPHENYL)ACETONITRILE is used as a starting material in the synthesis of specialty chemicals, such as fragrances, flavorings, and other high-value compounds, due to its unique chemical properties and reactivity.

InChI:InChI=1/C8H7NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3H2

Upstream product

• 66581-99-5 2-hydroxy-5-cyanomethylphenylethan-2-one 
• 4439-02-5 3,4-methylenedioxyphenylacetonitrile 
• 93-17-4 3,4-dimethoxyphenylacetonitrile 
• 27472-21-5 3,4-diethoxyphenylacetonitrile 
• 118-93-4 o-hydroxyacetophenone 
• 30787-43-0 5'-(chloromethyl)-2'-hydroxyacetophenone 

Downstream Products

• 102-32-9 3,4-dihydroxyphenylacetate 
• 113915-28-9 C₁₂H₁₃F₆NO₂ 
• 1439376-29-0 2-(3,4-bis(2,2,2-trifluoroethoxy)phenyl)acetonitrile 
• 10597-60-1 hydroxytyrosol 
• 25379-88-8 2-(3,4-dihydroxyphenyl)acetic acid methyl ester 
• 69769-47-7 2-(3,4-(diisopropoxy)phenyl)-acetonitrile 
• 1425539-72-5 (2Z)-2-(3,4-diisopropoxy phenyl)-3-{4-[(11-hydroxyundecyl)oxy]-3-methoxyphenyl}prop-2-enenitrile 
• 1425539-79-2 11-{4-[(Z)-2-cyano-2-(3,4-dimethoxyphenyl)ethenyl]-2-methoxyphenoxy}undecyl 2-methylacrylate 
• 27472-21-5 3,4-diethoxyphenylacetonitrile 
• 244614-76-4 (3,4-bis-heptyloxy-phenyl)-acetonitrile 
• 643727-00-8 [3-Hydroxy-4-oxo-cyclohexa-2,5-dien-(E)-ylidene]-acetonitrile 
• 643727-00-8 [3-Hydroxy-4-oxo-cyclohexa-2,5-dien-(Z)-ylidene]-acetonitrile 

Relevant academic research and scientific papers

METHOD FOR PREPARATION OF HYDROXYTYROSOL

The invention discloses a method for the preparation of (3,4-dihydroxyphenyl)acetic acid or its ester starting from the respective nitrile, and the conversion of (3,4-dihydroxyphenyl)acetic acid ester to hydroxytyrosol.

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

MODULATORS OF LIPID STORAGE

Disclosed are compounds of formulas I, II, and III: Formulas I, II, and III wherein R1-R19 and n are as described herein, or pharmaceutically acceptable salts thereof, or an enantiomer thereof or a conjugate thereof wherein the conju

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Modulators of ATP-binding cassette transporters

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Process of preparing discotic liquid crystalline compounds

The invention relates to a process of preparing a discotic liquid crystalline compound by intramolecular oxidative cyclisation of a diaryl compound in an organic solvent in the presence of a strong acid, characterized in that an oxidative agent comprising a chrom(VI)oxide derivative is used, to discotic liquid crystalline compounds obtainable from said process, to liquid crystalline media, (co)polymers or polymer networks with columnar phases comprising said discotic liquid crystalline compounds, and to the use of said discotic liquid crystalline compounds, liquid crystalline media or liquid crystalline (co)polymers with columnar phases for liquid crystal displays, optical elements like polarizers, compensators or colour filters, chemical sensors, charge transport materials, optical storage media, nonlinear optics, decorative pigments, adhesive or synthetic resins with anisotropic mechanical properties.